Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website http://www.gpo.gov/fdsys; (3) the federal government Internet portal USA.gov; or (4) a web search conducted using a commercial search engine such as http://www.google.com.
Accession Number ADA566413
Title Targeted Lymphoma Cell Death by Novel Signal Transduction Modifications.
Publication Date Jul 2011
Media Count 33p
Personal Author J. Tuscano
Abstract The proposed research set to; (1) create and characterize CD22- binding peptides that initiate signal transduction and apoptosis in non-Hodgkin s lymphoma (NHL), (2) optimize CD22-mediated signal transduction and lymphomacidal properties of ligand blocking anti-CD22 monoclonal antibodies (mAbs) and peptides with CD22-specific phosphatase inhibition and (3) correlate mAb-mediated and anti-CD22 peptide-mediated in vivo physiologic changes, efficacy, and tumor targeting using advanced immuno-positron emission topography (i-PET) and FDG-PET imaging technology. Since funding we have identified five peptides that are based on CDR s of anti-CD22 mAbs. Peptide 5 has been characterized and described in the annual report for year 1 and 2. Because peptide 5 was not target specific it could not be developed further. We then created reagents in year 3 to optimize targeting (CD22 + epithelial cell line and a new combinatorial peptide library). Within year 4 we identified addition peptides that one of which was B cell and CD22 specific (peptide No. 8). This peptide was found to induce effective cell killing in the lymphoma cell line, Ramos. We have now begun to characterize the specificity, signaling, cytotoxic and apoptotic potential.
Keywords Apoptosis
B lymphocytes
Cells(Biology)
Chemical agents
Cytotoxins
Death
Epithelium
Lymphomas
Neoplasms
Peptides
Topography


 
Source Agency Non Paid ADAS
NTIS Subject Category 57A - Anatomy
57S - Physiology
57E - Clinical Medicine
57Y - Toxicology
Corporate Author California Univ., Davis.
Document Type Technical report
Title Note Final rept. 15 Jun 2007-14 Jun 2011.
NTIS Issue Number 1307
Contract Number W81XWH-07-1-0471

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader